Related Experiment Video

Updated: Sep 20, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

601

The Efficacy of Using Oral Sodium Cromoglycate for Controlling Epidermolysis Bullosa-Related Pruritus

Sera Sarsam1,2, Annabel Stevenson3,4,5,6, Dédée F Murrell1,2,7

  • 1Department of Dermatology, St George Hospital, Sydney, New South Wales, Australia.

The Australasian Journal of Dermatology
|May 24, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
drug repurposingepidermolysis bullosapruritussodium cromoglycate

More Related Videos

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

919
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.1K

Related Experiment Videos

Last Updated: Sep 20, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

601
Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

919
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.1K

Related Concept Videos

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

712
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
712
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.8K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K

Articles linked to this work by shared authors, journal, and citation graph.

External Genital Cutaneous Sarcoidosis Mimicking Lichen Sclerosus.

The Australasian journal of dermatology·2026

Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial.

The British journal of dermatology·2026

Reassessing Remission in Pemphigus Vulgaris: Beyond Complete Remission Towards Meaningful Disease Control.

International journal of dermatology·2026

Delgocitinib cream formulation demonstrates a dose-dependent response in adults with mild to severe atopic dermatitis: results from an 8-week randomised Phase IIb trial.

The British journal of dermatology·2026

Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual-Center Study.

The Journal of dermatology·2026

Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials.

The British journal of dermatology·2026

Detection of Anti-IgE Antibodies Against Basement Membrane Zone in Bullous Pemphigoid by Direct Immunofluorescence: Prevalence, Associations and Significance.

The Australasian journal of dermatology·2026

Perineal Nodular Induration (Cyclist's Nodule).

The Australasian journal of dermatology·2026

The Development of Non-Tuberculosis Mycobacterial Infections in Sézary Syndrome: A Case Report of Two Patients.

The Australasian journal of dermatology·2026

Primary Cutaneous Gamma-Delta T-Cell Lymphoma With Unusual Clinicopathological Characteristics: A Study of Three Patients With Molecular Characterization.

The Australasian journal of dermatology·2026

Efficacy and Safety of 755-nm Picosecond Alexandrite Laser for Acquired Bilateral Naevus of Ota-Like Macules (Hori Naevus): A Systematic Review and Meta-Analysis.

The Australasian journal of dermatology·2026

Long-term efficacy of the Astragalus-Salvia miltiorrhiza botanical drug pair in stable coronary artery disease and a nomogram for predicting frequent hospitalization: a real-world retrospective cohort study.

Frontiers in pharmacology·2026

Systematic allergological evaluation enables NSAID allergy delabeling and identification of safe alternatives in adults.

Allergologia et immunopathologia·2026

Canada's crackdown on poppers and trends in crystal methamphetamine use among sexual and gender diverse men: a secondary data analysis.

The International journal on drug policy·2026

A Look Back at Mercury Soap as a Treatment for Yaws.

The American Journal of dermatopathology·2026

Chelidonium majus L. alkaloid extract encapsulated in human serum albumin nanoparticles induces mitochondria-mediated apoptosis in HeLa cell line.

Cellular and molecular biology (Noisy-le-Grand, France)·2026

Reduced severe infection risk with avacopan in ANCA-associated vasculitis: a multicentre REVEAL cohort with time-varying exposure modelling.

Rheumatology (Oxford, England)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us